While recent in vitro study suggested that FOXF2 binds to the promoter and represses the expression of FOXQ1 in a breast cancer cell line (Kang et al., 2019), our in vivo data demonstrated a cis-regulation of Foxq1 expression by the Foxf2 gene disruption. The gene discussed is FOXQ1; the disease is breast cancer.